EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies in the clinical microbiology laboratory: an American perspective

Corrie C Simons, Gerald A Capraro

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Corrie C Simons und 1 weiteren Autor:innen. Beteiligte Einrichtung: Quality Department, Mako Medical Laboratories, LLC, Raleigh, NC, USA. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: bioMérieux.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical microbiology laboratories are responsible for confirming the aetiology of infectious diseases and providing antimicrobial susceptibility testing results. Traditional culture-based testing can be augmented by more rapid testing modalities to provide clinically actionable information as quickly as possible. Despite improvements in patient outcomes, many clinical microbiology laboratories are facing challenges to in-sourcing these technologies. Depending on a multitude of factors, including size, location and patient population served, these barriers may affect some laboratories and hospital systems to greater or lesser extents than others. It will be up to each individual facility to ascertain its ability to overcome barriers. To aid in this self-assessment, we present for thoughtful consideration a discussion of the barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies, with specific attention to matters of financial cost, staff expertise, operational issues and stakeholder buy-in.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microbial Sensitivity TestsHumansAnti-Bacterial AgentsBacteriaCommunicable DiseasesLaboratories, ClinicalUnited States

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Quality Department, Mako Medical Laboratories, LLC, Raleigh, NC, USA.
  • Center for Esoteric Testing, Laboratory Corporation of America, Holdings, Burlington, NC, USA.

Förderung

  • bioMérieux

Zitieren

APA

Simons, C. C., & Capraro, G. A. (2024). Barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies in the clinical microbiology laboratory: an American perspective. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae279

Vancouver

Simons CC, Capraro GA. Barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies in the clinical microbiology laboratory: an American perspective. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae279

BibTeX
@article{Simons2024,
  author = {Simons, Corrie C and Capraro, Gerald A},
  title = {Barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies in the clinical microbiology laboratory: an American perspective},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae279}
}
Kostenlos starten →